0.32
Ani Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
0.34
FY23:
0.52
FY24:
0.53
FY25:
0.75
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.45
FY22:
0.42
FY23:
0.38
FY24:
0.76
FY25:
0.69
Total assets
Change from FY21 to FY25
billions USD
FY21:
0.77
FY22:
0.76
FY23:
0.90
FY24:
1.28
FY25:
1.44
Liabilities & Equity
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.09
FY22:
0.10
FY23:
0.15
FY24:
0.19
FY25:
0.28
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.33
FY22:
0.32
FY23:
0.30
FY24:
0.66
FY25:
0.62
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.33
FY22:
0.31
FY23:
0.43
FY24:
0.40
FY25:
0.54
Total liabilities & equity
billions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
1.44
All amounts in billions USD